Literature DB >> 10075680

Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2.

H B Huang1, A Horiuchi, T Watanabe, S R Shih, H J Tsay, H C Li, P Greengard, A C Nairn.   

Abstract

Phospho-DARPP-32 (where DARPP-32 is dopamine- and cAMP-regulated phosphoprotein, Mr 32,000), its homolog, phospho-inhibitor-1, and inhibitor-2 are potent inhibitors (IC50 approximately 1 nM) of the catalytic subunit of protein phosphatase-1 (PP1). Our previous studies have indicated that a region encompassing residues 6-11 (RKKIQF) and phospho-Thr-34, of phospho-DARPP-32, interacts with PP1. However, little is known about specific regions of inhibitor-2 that interact with PP1. We have now characterized in detail the interaction of phospho-DARPP-32 and inhibitor-2 with PP1. Mutagenesis studies indicate that within DARPP-32 Phe-11 and Ile-9 play critical roles, with Lys-7 playing a lesser role in inhibition of PP1. Pro-33 and Pro-35 are also important, as is the number of amino acids between residues 7 and 11 and phospho-Thr-34. For inhibitor-2, deletion of amino acids 1-8 (I2-(9-204)) or 100-204 (I2-(1-99)) had little effect on the ability of the mutant proteins to inhibit PP1. Further deletion of residues 9-13 (I2-(14-204)) resulted in a large decrease in inhibitory potency (IC50 approximately 800 nM), whereas further COOH-terminal deletion (I2-(1-84)) caused a moderate decrease in inhibitory potency (IC50 approximately 10 nM). Within residues 9-13 (PIKGI), mutagenesis indicated that Ile-10, Lys-11, and Ile-13 play critical roles. The peptide I2-(6-20) antagonized the inhibition of PP-1 by inhibitor-2 but had no effect on inhibition by phospho-DARPP-32. In contrast, the peptide D32-(6-38) antagonized the inhibition of PP1 by phospho-DARPP-32, inhibitor-2, and I2-(1-120) but not I2-(85-204). These results indicate that distinct amino acid motifs contained within the NH2 termini of phospho-DARPP-32 (KKIQF, where italics indicate important residues) and inhibitor-2 (IKGI) are critical for inhibition of PP1. Moreover, residues 14-84 of inhibitor-2 and residues 6-38 of phospho-DARPP-32 share elements that are important for interaction with PP1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075680     DOI: 10.1074/jbc.274.12.7870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Mutations of the serine phosphorylated in the protein phosphatase-1-binding motif in the skeletal muscle glycogen-targeting subunit.

Authors:  J Liu; J Wu; C Oliver; S Shenolikar; D L Brautigan
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein.

Authors:  David L Satinover; Craig A Leach; P Todd Stukenberg; David L Brautigan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

3.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 4.  cAMP regulation of protein phosphatases PP1 and PP2A in brain.

Authors:  Shannon N Leslie; Angus C Nairn
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-09-18       Impact factor: 4.739

5.  The Toxoplasma gondii inhibitor-2 regulates protein phosphatase 1 activity through multiple motifs.

Authors:  Quentin Deveuve; Kevin Lesage; Thomas Mouveaux; Mathieu Gissot
Journal:  Parasitol Res       Date:  2017-06-30       Impact factor: 2.289

6.  Protein phosphatase 1γ isoforms linked interactions in the brain.

Authors:  Sara L C Esteves; Luís Korrodi-Gregório; Cândida Z Cotrim; Paula J M van Kleeff; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

7.  Identification of AKAP79 as a protein phosphatase 1 catalytic binding protein.

Authors:  Andrew V Le; Steven J Tavalin; Kimberly L Dodge-Kafka
Journal:  Biochemistry       Date:  2011-05-16       Impact factor: 3.162

8.  GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.

Authors:  Qing-Rong Liu; Ping-Wu Zhang; Zhicheng Lin; Qi-Fu Li; Amina S Woods; Juan Troncoso; George R Uhl
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

9.  Detailed structural characterization of unbound protein phosphatase 1 inhibitors.

Authors:  Barbara Dancheck; Angus C Nairn; Wolfgang Peti
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

10.  Temporal sensitivity of protein kinase a activation in late-phase long term potentiation.

Authors:  MyungSook Kim; Ted Huang; Ted Abel; Kim T Blackwell
Journal:  PLoS Comput Biol       Date:  2010-02-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.